Quantitative PCR (q-PCR) analysis of cells derived from six AML patients showed a higher HDAC2 expression as compared to normal expression levels in CD34+ myeloid progenitors (Figure 1A and Table 1). The gene discussed is CD34; the disease is acute myeloid leukemia.